Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC2185
TNBC
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
9421.021
uM
1.64960
2.88290
-1.0000 -0.9906 1.9565 0.6753
0.9969
0.3726
SUM1315MO2
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
9797.017
uM
0.92127
2.12350
-1.0000 -1.0000 1.3156 0.7710
0.9823
0.4824
HCC1187
TNBC
Basal A
Cisplatin
DNA cross-linker
DNA cross-linker
7811.017
uM
1.68090
2.53690
-1.0000 -1.0000 2.6690 0.9047
0.7309
0.3604
HCC1187
TNBC
Basal A
Cisplatin
DNA cross-linker
DNA cross-linker
9244.021
uM
2.02180
2.59060
-1.0000 -0.9970 4.4235 0.7319
0.9785
0.4542
HCC1187
TNBC
Basal A
Epirubicin
TOP2
TOP
7811.017
uM
0.08798
0.25888
-1.0000 -1.0000 1.0180 1.0515
0.9521
0.3604
HCC38
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
10268.12
uM
inf
inf
-1.0000 -1.0000 0.0000 1.2668
0.5308
0.3272
MDA-MB-453
TNBC
Luminal
Vinorelbine
TUBB
TUBB
9708.006
uM
inf
inf
-1.0000 -1.0000 0.0000 1.6076
0.3995
0.6313
LY2
HR+
Luminal
GSK1838705A
IGF1R
RTK
7477.071
uM
0.62597
1.35510
-1.0000 -0.9841 1.4086 0.6625
0.9893
0.5122
MDA-MB-361
HER2amp
Luminal
Omipalisib
PI3K
PI3K
10643.087
uM
0.00172
0.00488
-1.0000 -0.9991 1.0559 1.3640
0.9987
0.6516
HCC1187
TNBC
Basal A
Methylglyoxal
13726.184
uM
0.99124
16.40040
-1.0000 -1.0000 0.3915 1.2606
0.7991
0.3574
MDA-MB-361
HER2amp
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10643.142
uM
0.20699
0.79038
-1.0000 -1.0000 0.8199 0.7668
0.9906
0.5166
HCC1187
TNBC
Basal A
Oxaliplatin
DNA cross-linker
DNA cross-linker
7811.011
uM
0.26894
0.77535
-1.0000 -1.0000 1.0376 1.1173
0.9558
0.4400
MX1
Unknown
Unknown
Bromopyruvic acid
Hexokinase II
Metabolism
12667.177
uM
0.02030
0.02529
-1.0000 -1.0000 5.0000 1.1110
0.9986
0.5892
HCC2185
TNBC
Luminal
Oxaliplatin
DNA cross-linker
DNA cross-linker
7848.011
uM
3.65840
8.42860
-1.0000 -1.0000 1.3163 0.6851
0.9953
0.3405
SUM1315MO2
TNBC
Basal B
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
9044.067
uM
0.05573
1.21580
-1.0000 -1.0000 0.3564 0.8720
0.5906
0.3210
MX1
Unknown
Unknown
Olomoucine II
CDK1
CDK
10644.147
uM
6.00730
7.48350
-1.0000 -1.0000 5.0000 0.4357
0.9851
0.4349
Hs 578T
TNBC
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7471.092
uM
3.33160
4.13810
-1.0000 -0.9781 5.0000 0.8415
0.9628
0.3860
BT-474
HER2amp
Luminal
Doxorubicin
TOP2
TOP
9163.121
uM
0.18301
0.22105
-1.0000 -0.7856 5.0000 0.7812
0.9752
0.4382
HCC2185
TNBC
Luminal
Oxaliplatin
DNA cross-linker
DNA cross-linker
9421.021
uM
3.32830
5.08560
-1.0000 -0.9677 2.5400 0.7050
0.9975
0.3726
HCC38
TNBC
Basal B
Carboplatin
DNA cross-linker
DNA cross-linker
10268.12
uM
0.41958
0.88930
-1.0000 -0.9927 1.4560 1.1119
0.9972
0.3272
HCC1395
TNBC
Basal B
CGC-11047
Polyamine analogue
9258.026
uM
0.44087
35.50130
-1.0000 -1.0000 0.2503 0.8247
0.7494
0.5632
HCC1395
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
9258.03
uM
1.05110
2.06760
-1.0000 -1.0000 1.6238 0.7227
0.9985
0.4015
HCC1395
TNBC
Basal B
GSK1070916
AURK
AURK
9254.001
uM
5.38610
6.70950
-1.0000 -0.9998 5.0000 0.3079
0.9082
0.3986